Skip to main content
Clinical Trials/CTRI/2019/06/019584
CTRI/2019/06/019584CompletedNot Applicable

Evaluation of the irritation potential of Skin and Hair Care Formulations on healthy human subjects.

Mountain Valley Springs India Pvt Ltd1 site in 1 country24 target enrollmentStarted: December 6, 2019Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
24
Locations
1
Primary Endpoint
Safety assessment of products

Study Overview

Brief Summary

Single Application Semi occlusive, Closed Patch test is conducted to measure the irritation potential of cosmetic products on the skin

Objective: To evaluate the irritation potential on healthy human subjects of Skin Care Formulations.

Duration of study: 8 days study

**Kinetics: T0 (**Evaluation of test sites by Dermatologist, Patch application)

T1(Patch removal)

T2(Evaluation of test sites by Dermatologist and Subject post 24 hrs of patch removal),

T8 (Evaluation of test sites by Dermat and Subject post 1 week of patch removal and tracking the positive cases)

Population 24 healthy subjects (12 males + 12 females)

The test area is checked for erythema and oedema caused due to the products and compared with positive control.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Not Applicable

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Healthy human subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) 2) Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….).

Exclusion Criteria

  • For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic, Being asthmatic, Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis.

Outcomes

Primary Outcomes

Safety assessment of products

Time Frame: Baseline,0 hrs,24 hrs&7 days

Secondary Outcomes

  • Not Applicable(Not Applicable)

Investigators

Sponsor
Mountain Valley Springs India Pvt Ltd
Sponsor Class
Other [fmcg]

Study Sites (1)

Loading locations...

Similar Trials